Cantor Fitzgerald Starts Cubist Pharmaceuticals (CBST) at Sell, Sees Slowing Revenue Trajectory
Tweet Send to a Friend
Cantor Fitzgerald initiates coverage on Cubist Pharmaceuticals (NASDAQ: CBST) with a Sell. PT $37.00.
The firmcommetns, "CBST ran up ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firmcommetns, "CBST ran up ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
